id CRUZ_5bb463a24bd8b5644a72793a5b6389bc
oai_identifier_str oai:www.arca.fiocruz.br:icict/46586
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Tegally, HouriiyahWilkinson, EduanLessells, RichardGiandhari, JenniferPillay, SureshneeMsomi, NokukhanyaMlisana, KolekaBhiman, Jinal N.von Gottberg, AnneWalaza, SibongileFonseca, VagnerAllam, MushalIsmail, ArshadGlass, Allison J.Engelbrecht, SusanVan Zy, GertPreiser, WolfgangWilliamson, CarolynPetruccione, FrancescoSigal, AlexGazy, InbalHardie, DianaHsiao, Nei-yuanMartin, DarrenYork, DenisGoedhals, DominiqueSan, Emmanuel JamesGiovanetti, MartaLourenço, JoséAlcantara, Luiz Carlos JuniorOliveira, Tulio de2021-04-08T20:30:01Z2021-04-08T20:30:01Z2021TEGALLY, Houriiyah et al. Sixteen novel lineages of SARS-CoV-2 in South Africa. Nature Medicine, v. 27, n. 3, p. 440-446, Mar. 2021.1078-8956https://www.arca.fiocruz.br/handle/icict/4658610.1038/s41591-021-01255-3engNature Publishing GroupSARS-CoV-2Dezesseis novas linhagensÁfrica do SulVariantesSARS-CoV-2VariantsSouth AfricaSixteen novel lineagesSixteen novel lineages of SARS-CoV-2 in South Africainfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleKwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.Discipline of Virology, University of KwaZulu-Natal, Durban, South Africa.National Health Laboratory Service, Springbok, South Africa.National Institute For Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa.National Institute For Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa / National Institute For Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa.National Institute For Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa / School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.National Institute For Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa.National Institute For Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa.School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa / Department of Molecular Pathology, Lancet Laboratories, Johannesburg, South Africa;Division of Medical Virology at NHLS Tygerberg Hospital, Stellenbosch University, Stellenbosch, South Africa.Division of Medical Virology at NHLS Tygerberg Hospital, Stellenbosch University, Stellenbosch, South Africa.Division of Medical Virology at NHLS Tygerberg Hospital, Stellenbosch University, Stellenbosch, South Africa.Division of Medical Virology at NHLS Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.Centre for Quantum Technology, University of KwaZulu-Natal, Durban, South Africa / National Institute for Theoretical Physics (NITheP), KwaZulu-Natal, South Africa.Africa Health Research Institute, Durban, South Africa / School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa / Max Planck Institute for Infection Biology, Berlin, Germany.KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.Division of Medical Virology at NHLS Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.Division of Medical Virology at NHLS Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.Division of Computational Biology, Department of Integrative Biomedical Sciences, Institute of Infectious Diseases and Molecular medicine, The University of Cape Town, Cape Town, South Africa.Molecular Diagnostics Services, Durban, South Africa.Division of Virology at NHLS Universitas Academic Laboratories, University of The Free State, Bloemfontein, South Africa.KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Flavivírus. Rio de Janeiro, RJ, Brasil.Department of Zoology, University of Oxford, Oxford, UK.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Flavivírus. Rio de Janeiro, RJ, Brasil / Universidade Federal de Minas Gerais. Instituto de Ciências Biológicas. Laboratorio de Genetica Celular e Molecular. Belo Horizonte,., MG, Brasil.KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa / Department of Global Health, University of Washington, Seattle, WA, USA / Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa.The first severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in South Africa was identified on 5 March 2020, and by 26 March the country was in full lockdown (Oxford stringency index of 90)1. Despite the early response, by November 2020, over 785,000 people in South Africa were infected, which accounted for approximately 50% of all known African infections2. In this study, we analyzed 1,365 near whole genomes and report the identification of 16 new lineages of SARS-CoV-2 isolated between 6 March and 26 August 2020. Most of these lineages have unique mutations that have not been identified elsewhere. We also show that three lineages (B.1.1.54, B.1.1.56 and C.1) spread widely in South Africa during the first wave, comprising ~42% of all infections in the country at the time. The newly identified C lineage of SARS-CoV-2, C.1, which has 16 nucleotide mutations as compared with the original Wuhan sequence, including one amino acid change on the spike protein, D614G (ref. 3), was the most geographically widespread lineage in South Africa by the end of August 2020. An early South African-specific lineage, B.1.106, which was identified in April 2020 (ref. 4), became extinct after nosocomial outbreaks were controlled in KwaZulu-Natal Province. Our findings show that genomic surveillance can be implemented on a large scale in Africa to identify new lineages and inform measures to control the spread of SARS-CoV-2. Such genomic surveillance presented in this study has been shown to be crucial in the identification of the 501Y.V2 variant in South Africa in December 2020.info:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/46586/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINALMartaGiovanettti_LuizCAlcantara_etal_IOC_2021.pdf.pdfMartaGiovanettti_LuizCAlcantara_etal_IOC_2021.pdf.pdfapplication/pdf12394983https://www.arca.fiocruz.br/bitstream/icict/46586/2/MartaGiovanettti_LuizCAlcantara_etal_IOC_2021.pdf.pdfa3fea24109644a7a4c6a0a7879b3bf52MD52TEXTMartaGiovanettti_LuizCAlcantara_etal_IOC_2021.pdf.pdf.txtMartaGiovanettti_LuizCAlcantara_etal_IOC_2021.pdf.pdf.txtExtracted texttext/plain61545https://www.arca.fiocruz.br/bitstream/icict/46586/3/MartaGiovanettti_LuizCAlcantara_etal_IOC_2021.pdf.pdf.txt169eb11fd3c0150d3e4f7401d37d530dMD53icict/465862022-06-24 13:11:04.531oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352022-06-24T16:11:04Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv Sixteen novel lineages of SARS-CoV-2 in South Africa
title Sixteen novel lineages of SARS-CoV-2 in South Africa
spellingShingle Sixteen novel lineages of SARS-CoV-2 in South Africa
Tegally, Houriiyah
SARS-CoV-2
Dezesseis novas linhagens
África do Sul
Variantes
SARS-CoV-2
Variants
South Africa
Sixteen novel lineages
title_short Sixteen novel lineages of SARS-CoV-2 in South Africa
title_full Sixteen novel lineages of SARS-CoV-2 in South Africa
title_fullStr Sixteen novel lineages of SARS-CoV-2 in South Africa
title_full_unstemmed Sixteen novel lineages of SARS-CoV-2 in South Africa
title_sort Sixteen novel lineages of SARS-CoV-2 in South Africa
author Tegally, Houriiyah
author_facet Tegally, Houriiyah
Wilkinson, Eduan
Lessells, Richard
Giandhari, Jennifer
Pillay, Sureshnee
Msomi, Nokukhanya
Mlisana, Koleka
Bhiman, Jinal N.
von Gottberg, Anne
Walaza, Sibongile
Fonseca, Vagner
Allam, Mushal
Ismail, Arshad
Glass, Allison J.
Engelbrecht, Susan
Van Zy, Gert
Preiser, Wolfgang
Williamson, Carolyn
Petruccione, Francesco
Sigal, Alex
Gazy, Inbal
Hardie, Diana
Hsiao, Nei-yuan
Martin, Darren
York, Denis
Goedhals, Dominique
San, Emmanuel James
Giovanetti, Marta
Lourenço, José
Alcantara, Luiz Carlos Junior
Oliveira, Tulio de
author_role author
author2 Wilkinson, Eduan
Lessells, Richard
Giandhari, Jennifer
Pillay, Sureshnee
Msomi, Nokukhanya
Mlisana, Koleka
Bhiman, Jinal N.
von Gottberg, Anne
Walaza, Sibongile
Fonseca, Vagner
Allam, Mushal
Ismail, Arshad
Glass, Allison J.
Engelbrecht, Susan
Van Zy, Gert
Preiser, Wolfgang
Williamson, Carolyn
Petruccione, Francesco
Sigal, Alex
Gazy, Inbal
Hardie, Diana
Hsiao, Nei-yuan
Martin, Darren
York, Denis
Goedhals, Dominique
San, Emmanuel James
Giovanetti, Marta
Lourenço, José
Alcantara, Luiz Carlos Junior
Oliveira, Tulio de
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Tegally, Houriiyah
Wilkinson, Eduan
Lessells, Richard
Giandhari, Jennifer
Pillay, Sureshnee
Msomi, Nokukhanya
Mlisana, Koleka
Bhiman, Jinal N.
von Gottberg, Anne
Walaza, Sibongile
Fonseca, Vagner
Allam, Mushal
Ismail, Arshad
Glass, Allison J.
Engelbrecht, Susan
Van Zy, Gert
Preiser, Wolfgang
Williamson, Carolyn
Petruccione, Francesco
Sigal, Alex
Gazy, Inbal
Hardie, Diana
Hsiao, Nei-yuan
Martin, Darren
York, Denis
Goedhals, Dominique
San, Emmanuel James
Giovanetti, Marta
Lourenço, José
Alcantara, Luiz Carlos Junior
Oliveira, Tulio de
dc.subject.other.pt_BR.fl_str_mv SARS-CoV-2
Dezesseis novas linhagens
África do Sul
Variantes
topic SARS-CoV-2
Dezesseis novas linhagens
África do Sul
Variantes
SARS-CoV-2
Variants
South Africa
Sixteen novel lineages
dc.subject.en.pt_BR.fl_str_mv SARS-CoV-2
Variants
South Africa
Sixteen novel lineages
description KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
publishDate 2021
dc.date.accessioned.fl_str_mv 2021-04-08T20:30:01Z
dc.date.available.fl_str_mv 2021-04-08T20:30:01Z
dc.date.issued.fl_str_mv 2021
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv TEGALLY, Houriiyah et al. Sixteen novel lineages of SARS-CoV-2 in South Africa. Nature Medicine, v. 27, n. 3, p. 440-446, Mar. 2021.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/46586
dc.identifier.issn.pt_BR.fl_str_mv 1078-8956
dc.identifier.doi.none.fl_str_mv 10.1038/s41591-021-01255-3
identifier_str_mv TEGALLY, Houriiyah et al. Sixteen novel lineages of SARS-CoV-2 in South Africa. Nature Medicine, v. 27, n. 3, p. 440-446, Mar. 2021.
1078-8956
10.1038/s41591-021-01255-3
url https://www.arca.fiocruz.br/handle/icict/46586
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Nature Publishing Group
publisher.none.fl_str_mv Nature Publishing Group
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/46586/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/46586/2/MartaGiovanettti_LuizCAlcantara_etal_IOC_2021.pdf.pdf
https://www.arca.fiocruz.br/bitstream/icict/46586/3/MartaGiovanettti_LuizCAlcantara_etal_IOC_2021.pdf.pdf.txt
bitstream.checksum.fl_str_mv 5a560609d32a3863062d77ff32785d58
a3fea24109644a7a4c6a0a7879b3bf52
169eb11fd3c0150d3e4f7401d37d530d
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1813009220571758592